U.S. Federal Communications Commission to provide $200 million to bankroll hospital telehealth equipment in response to COVID-19

April 03, 2020
Other financial More...
by Danielle Bradnan
Truly disruptive

This is important not only for managing the COVID-19 crisis but also for establishing telehealth services in hospitals throughout the U.S. After this crisis has passed (and estimates for a vaccine are 18 months out), this equipment is not going to go away. Physicians and patients will have developed a comfort with these tools – and, coupled with access to equipment and a newly relaxed regulatory policy, many of the historical infrastructural hurdles to telehealth adoption will be removed. Clients should anticipate that telehealth is going to continue to grow and should look to invest in flavors of telehealth that support video conferencing, such as remote monitoring devices like AliveCor's cardiac monitormHealth, and digital therapeutics.

For the original news article, click here .

Further Reading

Digital therapeutic Akili Interactive Labs to study effects of product on COVID-19 brain fog

News Commentary | April 15, 2021

As the immediate life‑threatening concerns of COVID‑19 begin to wane due to vaccines, there is a growing need to address the long‑term health impacts of the pandemic. Cognitive deficits, especially brain fog, are emerging as a common long‑term symptom. Akili is exploring its current offering for ... Not part of subscription

Digital tool pricing analysis: Chronic kidney disease management

Analyst Insight | May 19, 2021

Chronic Kidney Disease (CKD) The digital transformation of healthcare is enabling more effective ways of managing disease, and chronic kidney disease is no exception. The U.S. CDC estimates that 40% of people with severely reduced kidney function do not know they have it, as the symptoms are ... Not part of subscription

Babylon Health's acquisition of a physician group ensures continued reimbursements

News Commentary | June 10, 2021

Telehealth has represented big business during the COVID‑19 pandemic, and U.K.‑based Babylon Health is no exception. As temporary extensions for telehealth coverage expire in the U.S., Babylon will need to double down on human‑provided telehealth services (as opposed to chatbots and mHealth tools) ... Not part of subscription